After just one month of treatment, the marker of cancer in her blood returned to normal.
Basic science studies have identified cannabinoid receptors in ovarian cancer as potential therapeutic targets for cannabinoid use in treating malignancy.”Gynecologic Oncology Reports. Aug. 2019
April 2017: A rare and deadly form of ovarian cancer diagnosed in 81-yr-old woman.
May 2017: Begins treatment regime of CBD oil and a tablet containing amygdaline (derived from plant and fruit seeds).
June 2017: After just one month of treatment, the elevated level of cancer-marker Ca in her blood returned to normal.
July 2017: Size of the tumour had decreased.
Dec. 2018: “Clinically asymptomatic with a performance status of 0, which is unchanged from her performance status at time of diagnosis.”
Case study provided by UC San Diego Moores Cancer Center, La Jolla, California.
Dramatic response to Laetrile and cannabidiol (CBD) oil in a patient with metastatic low grade serous ovarian carcinoma. Gynecologic Oncology Reports. Aug. 2019.
Since 2011, CBD has been shown to decrease prostate and ovarian cancer cells.